Suspension of trading
Chimerix, Inc. Stock
Stocks
CMRX
US16934W1062
Biotechnology & Medical Research
|
Market Closed -
Nasdaq
16:00:00 2025-04-17 EDT
|
5-day change | 1st Jan Change | ||
| 8.540 USD | -.--% |
|
-.--% | - |
| 25-04-21 | Jazz Pharmaceuticals Completes $935 Million Acquisition of Chimerix | MT |
| 25-04-21 | Chimerix, Inc. Announces Alan Campion as the Chief Financial Officer | CI |
| Market Cap | 801M 712M 664M 605M 1.14B 77.01B 1.15B 8.04B 3.12B 39.37B 3.01B 2.94B 126B | P/E 2023 |
-1.03x | P/E 2024 | -3.52x |
|---|---|---|---|---|---|
| Enterprise Value | 671M 596M 556M 507M 956M 64.47B 965M 6.73B 2.61B 32.96B 2.52B 2.46B 106B | EV / Sales 2023 |
-295x | EV / Sales 2024 | 861x |
| Free-Float |
89.52% | Yield 2023 * |
-
| Yield 2024 | - |
| 3 years | 0.75 |  | 8.55 |
| 5 years | 0.75 | | 8.55 |
| 10 years | 0.75 | | 11.57 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 4/21/25 | Issuer sale | Chief Financial Officer | 1,015,869 | 1.1295% | ||
| 4/21/25 | Issuer sale | Chairman | 393,055 | 0.4370% | ||
| 4/21/25 | Issuer sale | Director | 631,523 | 0.7022% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -.--% | -.--% | +798.85% | 801M | |
| +4.16% | +3.04% | +49.37% | +94.17% | 74.16B | |
| -3.11% | -3.53% | +20.19% | +81.44% | 57.39B | |
| +0.89% | -0.63% | +2.17% | +36.19% | 47.64B | |
| +0.36% | +0.81% | +342.39% | +742.40% | 44.29B | |
| -0.96% | -4.50% | +24.96% | +35.38% | 42.5B | |
| -0.20% | -0.77% | +4.13% | +105.50% | 40.71B | |
| -0.54% | +2.93% | +9.31% | +50.41% | 30.97B | |
| -2.68% | +2.92% | +29.33% | +22.72% | 28.53B | |
| +0.05% | -1.64% | -8.14% | -11.37% | 24.34B | |
| Average | -0.20% | -0.53% | +47.37% | +195.57% | 39.13B | |
| Weighted average by Cap. | +0.12% | -0.84% | +56.84% | +139.61% |
| 2023 | 2024 | |
|---|---|---|
| Net sales | 324K 288K 269K 245K 462K 31.15M 466K 3.25M 1.26M 15.92M 1.22M 1.19M 51.1M | 212K 188K 176K 160K 302K 20.38M 305K 2.13M 824K 10.42M 796K 779K 33.44M |
| Net income | -82.1M -72.94M -68.08M -62.05M -117M -7.89B -118M -824M -319M -4.03B -308M -302M -12.95B | -88.39M -78.53M -73.3M -66.81M -126M -8.5B -127M -887M -344M -4.34B -332M -325M -13.94B |
| Net Debt | -181M -161M -150M -137M -258M -17.4B -260M -1.82B -704M -8.9B -680M -665M -28.55B | -130M -116M -108M -98.61M -186M -12.54B -188M -1.31B -507M -6.41B -490M -479M -20.58B |
Employees
79
- Stock Market
- Stocks
- CMRX Stock
Select your edition
All financial news and data tailored to specific country editions
